• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IDH1-R132 changes vary according to NPM1 and other mutations status in AML.

作者信息

Falini Brunangelo, Spinelli Orietta, Meggendorfer Manja, Martelli Maria Paola, Bigerna Barbara, Ascani Stefano, Stein Harald, Rambaldi Alessandro, Haferlach Torsten

机构信息

The Institute of Hematology and Research Center for Hemato-Oncological diseases (CREO), University of Perugia, Perugia, Italy.

The Institute of Hematology, Ospedale Giovanni XXIII, Bergamo, Italy.

出版信息

Leukemia. 2019 Apr;33(4):1043-1047. doi: 10.1038/s41375-018-0299-2. Epub 2019 Jan 8.

DOI:10.1038/s41375-018-0299-2
PMID:30622284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6484707/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb53/6484707/200eb23f3c4f/41375_2018_299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb53/6484707/ec1166ae9fb6/41375_2018_299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb53/6484707/200eb23f3c4f/41375_2018_299_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb53/6484707/ec1166ae9fb6/41375_2018_299_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb53/6484707/200eb23f3c4f/41375_2018_299_Fig2_HTML.jpg

相似文献

1
IDH1-R132 changes vary according to NPM1 and other mutations status in AML.在急性髓系白血病（AML）中，异柠檬酸脱氢酶1（IDH1）R132位点的改变根据核仁磷酸蛋白（NPM1）及其他突变状态而有所不同。
Leukemia. 2019 Apr;33(4):1043-1047. doi: 10.1038/s41375-018-0299-2. Epub 2019 Jan 8.
2
IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation.异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变对缺乏核仁磷酸蛋白1（NPM1）突变的急性髓系白血病患者具有不良影响。
Eur J Haematol. 2014 Jun;92(6):471-7. doi: 10.1111/ejh.12271. Epub 2014 Mar 3.
3
Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.1例马富西综合征患者中与杯状急性髓系白血病相关的IDH1和NPM1体细胞镶嵌突变
Int J Hematol. 2015 Dec;102(6):723-8. doi: 10.1007/s12185-015-1892-z. Epub 2015 Oct 27.
4
Mutation Analysis of IDH1/2 Genes in Unselected De novo Acute Myeloid Leukaemia Patients in India - Identification of A Novel IDH2 Mutation.印度未经选择的初发急性髓系白血病患者中IDH1/2基因的突变分析——一种新型IDH2突变的鉴定
Asian Pac J Cancer Prev. 2015;16(9):4095-101. doi: 10.7314/apjcp.2015.16.9.4095.
5
IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.在 1414 例 AML 患者中，检测到 6.6%存在 IDH1 突变，这些突变与年龄小于 60 岁的成年人中中等风险核型和不良预后以及未突变的 NPM1 状态相关。
Blood. 2010 Dec 16;116(25):5486-96. doi: 10.1182/blood-2010-02-267955. Epub 2010 Aug 30.
6
Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.异柠檬酸脱氢酶 1 和 2 突变作为非早幼粒细胞性急性髓系白血病预后指标的潜在应用：一项荟萃分析。
Leuk Lymphoma. 2012 Dec;53(12):2423-9. doi: 10.3109/10428194.2012.695359. Epub 2012 Jun 18.
7
Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients.中国患者中揭示的 IDH1 突变型急性髓系白血病的一些新特征。
Leuk Res. 2011 Oct;35(10):1301-6. doi: 10.1016/j.leukres.2011.01.019. Epub 2011 Feb 12.
8
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.IDH1 R132 突变和 IDH1 单核苷酸多态性在核型正常的急性髓系白血病中的影响：SNP rs11554137 是一个不良预后因素。
J Clin Oncol. 2010 May 10;28(14):2356-64. doi: 10.1200/JCO.2009.27.6899. Epub 2010 Apr 5.
9
Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations.异常的 HIF1-α 和 SIX-1 表达与 IDH1 突变的急性髓系白血病患者预后不良相关。
Cancer Control. 2024 Jan-Dec;31:10732748241271714. doi: 10.1177/10732748241271714.
10
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.伴有 IDH1/2 突变的 AML/MDS-EB 的单中心观察性研究：遗传特征、免疫表型、突变动力学和结果。
Hematology. 2023 Dec;28(1):2180704. doi: 10.1080/16078454.2023.2180704.

引用本文的文献

1
Recent Developments in Differentiation Therapy of Acute Myeloid Leukemia.急性髓系白血病分化治疗的最新进展
Cancers (Basel). 2025 Mar 28;17(7):1141. doi: 10.3390/cancers17071141.
2
Immunoediting in acute myeloid leukemia: Reappraising T cell exhaustion and the aberrant antigen processing machinery in leukemogenesis.急性髓系白血病中的免疫编辑：重新评估白血病发生中的T细胞耗竭及异常抗原加工机制。
Heliyon. 2024 Oct 25;10(21):e39731. doi: 10.1016/j.heliyon.2024.e39731. eCollection 2024 Nov 15.
3
The Leukemic Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs).
白血病突变损害原代人造血干细胞和祖细胞（HSPCs）的髓系和红系细胞分化。
Cancers (Basel). 2024 Jul 27;16(15):2675. doi: 10.3390/cancers16152675.
4
Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.NPM1 突变型 AML 的诊断和分子监测标准。
Blood Cancer Discov. 2024 Jan 8;5(1):8-20. doi: 10.1158/2643-3230.BCD-23-0144.
5
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias.NPM1突变型急性髓系白血病的遗传、表型及临床异质性
Biomedicines. 2023 Jun 24;11(7):1805. doi: 10.3390/biomedicines11071805.
6
Discovery of novel -R132C inhibitors through structure-based virtual screening.通过基于结构的虚拟筛选发现新型-R132C抑制剂。
Front Pharmacol. 2022 Sep 7;13:982375. doi: 10.3389/fphar.2022.982375. eCollection 2022.
7
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.基因组分析在髓系肿瘤和急性白血病中的临床决策应用。
Blood. 2022 Nov 24;140(21):2228-2247. doi: 10.1182/blood.2022015853.
8
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.异柠檬酸脱氢酶 1 和 2 突变亚组对异基因造血干细胞移植后急性髓系白血病患者的影响。
J Hematol Oncol. 2022 Sep 5;15(1):126. doi: 10.1186/s13045-022-01339-8.
9
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.异柠檬酸脱氢酶（IDH）突变在急性髓系白血病中的患病率及预后作用：GIMEMA AML1516方案的结果
Cancers (Basel). 2022 Jun 18;14(12):3012. doi: 10.3390/cancers14123012.
10
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.抗原呈递保障了造血干细胞库的完整性。
Cell Stem Cell. 2022 May 5;29(5):760-775.e10. doi: 10.1016/j.stem.2022.04.007.